Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found...
Enregistré dans:
Auteurs principaux: | Yuek Ling Chai, Joyce R. Chong, Ainiah R. Raquib, Xin Xu, Saima Hilal, Narayanaswamy Venketasubramanian, Boon Yeow Tan, Alan P. Kumar, Gautam Sethi, Christopher P. Chen, Mitchell K. P. Lai |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b1b12e90137f45e5a30c6c0e5d07ecd7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
par: Petra Popovics, et autres
Publié: (2021) -
Stroke Care in Pakistan
par: Anjum Farooq, et autres
Publié: (2021) -
Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression
par: Xing-Xing Yao, et autres
Publié: (2017) -
Plasma and follicular fluid osteopontin levels during ovarian cycle and their correlation with follicular fluid vascular endothelial growth factor levels
par: Yoshimitsu Kuwabara, et autres
Publié: (2021) -
A Pivotal Role for AP-1-Mediated Osteopontin Expression in the Increased Migration of Vascular Smooth Muscle Cells Stimulated With HMGB1
par: Eun Yeong Jeon, et autres
Publié: (2021)